Display options
Share it on

Interv Cardiol Clin. 2014 Jul;3(3):369-377. doi: 10.1016/j.iccl.2014.03.005. Epub 2014 Jun 28.

Predicting Contrast-induced Renal Complications in the Catheterization Laboratory.

Interventional cardiology clinics

Judith Kooiman, Hitinder S Gurm

Affiliations

  1. Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, South Holland, The Netherlands; Department of Nephrology, Leiden University Medical Center, Leiden, South Holland, The Netherlands. Electronic address: [email protected].
  2. Division of Cardiovascular Medicine, Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan Health System, University of Michigan Cardiovascular Center, 2A394, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-5853, USA.

PMID: 28582222 DOI: 10.1016/j.iccl.2014.03.005

Abstract

Risk scores should undergo 3 analytical phases before they are suitable for adoption in clinical practice, namely, derivation, external validation, and assessment of effect on clinical outcomes of use of the risk score in a so-called impact study. Major risk factors for renal complications after percutaneous coronary intervention are pre-existing chronic kidney disease, diabetes mellitus, use of a high contrast dose, and hemodynamic instability. Unfortunately, only 3 of these 10 risk scores have undergone external validation. As a result, there is a great need for further research on the already designed risk scores.

Copyright © 2014 Elsevier Inc. All rights reserved.

Keywords: Catheterization lab; Percutaneous coronary intervention; Renal complications

Publication Types